
Bleph-10 Coupons & Savings Card – Discount Prices from $19.95
Brand for: Sulfacetamide
My prescription
Edit
10ML of 10%, Sulfacetamide (1 Bottle)
Select pharmacy

CVS
$22.73
COUPON PRICE
Walgreens
$19.95
COUPON PRICE
Walmart
$23.65
COUPON PRICE
Albertsons
$34.55
COUPON PRICEBleph-10 savings card
Show this card to your pharmacist
Walgreens
$19.95
BIN
ID
PCN
GRP
015995
LHKPX273051
GDC
DR33
Powered by
Related sulfa antibiotics prescriptions
More prescriptions for skin infection
Related sulfa antibiotics prescriptions
More prescriptions for skin infection
Bleph-10 (Sulfacetamide) dosage forms
Dosage Quantity Price from Per unit 10ML of 10% 1 Bottle $22.73 $22.73 10ML of 10% 2 Bottles $27.16 $13.58 10ML of 10% 3 Bottles $31.58 $10.53
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 10ML of 10% | 1 Bottle | $22.73 | $22.73 |
| 10ML of 10% | 2 Bottles | $27.16 | $13.58 |
| 10ML of 10% | 3 Bottles | $31.58 | $10.53 |
What is Bleph 10 used to treat?
Bleph-10 is used to treat bacterial infections of the eye, such as conjunctivitis. It contains sulfacetamide sodium, which is a sulfonamide antibiotic that helps stop the growth of bacteria.
What are the ingredients in Bleph 10?
Bleph-10 contains the active ingredient sulfacetamide sodium, which is a sulfonamide antibiotic. The inactive ingredients may include thimerosal, sodium thiosulfate, sodium phosphate, monobasic, sodium phosphate, dibasic, and purified water. It is important to check the specific product packaging or consult a healthcare professional for the most accurate and up-to-date information.
Is Bleph-10 an antibiotic?
Yes, Bleph-10 is an antibiotic. It contains sulfacetamide sodium, which is used to treat bacterial infections of the eye.
What bacteria does sulfacetamide treat?
Sulfacetamide is effective against a variety of bacteria, primarily targeting gram-positive and some gram-negative bacteria. It is commonly used to treat bacterial infections caused by organisms such as Staphylococcus aureus, Streptococcus pneumoniae, and Escherichia coli.
